Prevent and Reverse Obesity in Children, Adolescents and Young Adults
NCT07035704 · Not yet recruiting
Last updated 2026-05-28This clinical trial tests a weight management program in children, adolescents, and young adults who are overweight to see how it affects their body weight.
What this study is testing ClinicalTrials.gov NCT07035704 ↗
Description as written by the study sponsor.
Obesity and overweight are non-communicable diseases with an increasing incidence in children, adolescents, and adults. International efforts to reverse the current epidemiological trend of rising overweight, obesity, and related diseases have so far been insufficient to achieve this goal. Therefore, a change in strategy-both at the individual and public health levels-is urgently needed. Searching the litterature, there are currently no studies employing a comprehensive, personalized, and multi-level strategy to induce stable changes in dietary and lifestyle habits, while also conducting careful follow-up of outcomes and exploring the pathogenic mechanisms affecting metabolic pathways, pro-inflammatory and systemic conditions, and intestinal permeability in overweight and obese patients. Evidence shows the beneficial effects of specific dietary patterns (e.g., the Mediterranean Diet) and a healthy lifestyle in reducing body/organ fat accumulation. However, a comprehensive evaluation of their effects-particularly following personalized strategies and careful follow-up-on the pathogenic mechanisms influencing cardiovascular and metabolic risk, pro-inflammatory status, and intestinal permeability in the medium-to-long term is still lacking.
Treatments tested
- MeD enriched with mushrooms Dietary supplement
Patients will receive the MeD personalized plan plus commercial mushrooms
- MeD enriched the Lebanese herbal mixture Za'atar Dietary supplement
Patients will receive the MeD personalized plan plus natural products/extracts of endemic plants (olive oil, herbs like Lebanese Za'atar).
- MeD Diet + semaglutinine or compatible treatment+ Za'atar or Mushroom (to be defined) Dietary supplement
Patients will receive counselling and personalized dietary strategy aimed at increasing the adherence to Mediterranean diet by means of use of visual communication (e.g., comics, cartoons, videos) and digital tools (i.e., games, apps), including a physical activity program with a personal trainer + semaglutinine or compatible treatment+ Za'atar or Mushroom (to be defined)
| Main thing measured | Weight (Kg) |
|---|---|
| Sponsor | piero portincasa |
| Conditions studied | Overweight (BMI > 25) |
| GLP-1 drugs | — |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07035704 ↗